The 2022 Women’s Venture Competition is open for applications until February 28, 2022, 11:59 PM Eastern Time.
The AIM-HI Women’s Venture Competition, in its third year, is open for women entrepreneurs! The program provides early-stage funding, coaching, and networking opportunities to women-led oncology startups to address unmet medical needs.
The winning company will receive a total of $1 million in investment from AIM-HI and co-investors, subject to due diligence and negotiation. Click here to download the flyer and help spread the word!
News
Applications Open for the 2022 AIM-HI Women’s Venture Competition!
We have great news to share! The 2022 AIM-HI Women’s Venture Competition…
2021 Women’s Venture Competition Announced Semi-Finalists!
The AIM-HI Accelerator Fund just announced 10 semi-finalists for the 2021 Women’s…
Applications Open for the 2021 AIM-HI Women’s Venture Competition!
Today is International Women’s Day. In honor of the occassion, the AIM-HI…
Winner of the AIM-HI Accelerator Fund’s Inaugural Women’s Venture Competition Announced
Privo Technologies to Receive $900,000 of Investment Funding Privo Technologies and its…
Our Partners & Sponsors
Privo Technologies has received investment of $900,000 – $300,000 from AIM-HI and matching investment from two supporters of the Competition! Read the press release.
Based in Peabody, Massachusetts, the company has developed a nano-engineered platform for redesigning the mechanism of action of potent cancer medicines. For more information, visit https://www.privotechnologies.com.